Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)

NAActive, not recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Cardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

Antioxidant cocktail

Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment

OTHER

Biopsy

Under sterile conditions, a small incision (¼ - ½ inch) by the study doctor will be made and the piece of fat will be taken out. Fat tissue was chosen for this study because it is a big source of small blood vessels which we are studying

OTHER

Placebo

Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment

DRUG

NMD; 0.4mg sub-lingual nitroglycerin spray

Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.

Trial Locations (1)

30912

Georgia Prevention Institute , Georgia Regents University, Augusta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Augusta University

OTHER